Position in NVS
as of Jun 30, 2026
· filed Aug 18, 2026
Position Value
$13,201,152
+$291,181 QoQ
Shares Held
84,234
-0.3% QoQ
Ownership
0.004%
of shares outstanding
% of Portfolio
0.14%
of 13F equity value
Holder Rank
#145
of 1,603 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in NVS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Beacon Pointe Advisors, LLC holds $381,609,244 across 14 Drug Manufacturers - General names. NVS ranks #8 (3.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
365,648 | $92,863,622 | |
| 2 | LLY |
ELI LILLY & Co
|
61,241 | $73,454,298 | |
| 3 | ABBV |
AbbVie Inc.
|
195,761 | $49,261,298 | |
| 4 | MRK |
Merck & Co., Inc.
|
363,066 | $46,653,981 | |
| 5 | AMGN |
Amgen Inc
|
108,053 | $39,128,152 | |
| 6 | PFE |
Pfizer Inc
|
1,161,607 | $27,971,496 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
232,697 | $13,408,001 | |
| 8 | NVS |
Novartis AG
This page
|
84,234 | $13,201,152 |
All Filings in NVS
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $13,201,152 | 84,234 | Shares | Sole | 2026-08-18 | |
| 2026-03-31 | $12,909,971 | 84,517 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $9,179,660 | 66,582 | Shares | Sole | 2026-02-18 | |
| 2025-09-30 | $8,179,275 | 63,781 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $7,394,316 | 61,105 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $6,517,901 | 58,467 | Shares | Sole | 2025-05-13 | |
| 2024-12-31 | $4,266,167 | 43,841 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $5,516,129 | 47,958 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $4,888,962 | 45,923 | Shares | Sole | 2024-08-12 | |
| 2024-03-31 | $4,325,185 | 44,714 | Shares | Sole | 2024-05-14 | |
| 2023-12-31 | $3,698,430 | 36,629 | Shares | Sole | 2024-02-08 | |
| 2023-09-30 | $3,292,624 | 32,325 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $1,119,495 | 11,094 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $831,772 | 9,041 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $1,349,550 | 14,876 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $1,140,682 | 15,007 | Shares | Sole | 2022-11-09 | |
| 2022-06-30 | $1,499,224 | 17,736 | Shares | Sole | 2022-08-11 | |
| 2022-03-31 | $2,831,780 | 32,271 | Shares | Sole | 2022-05-17 | |
| 2021-12-31 | $1,111,743 | 12,710 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $1,092,826 | 13,363 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $1,292,597 | 14,167 | Shares | Sole | 2021-08-17 | |
| 2021-03-31 | $561,689 | 6,571 | Shares | Sole | 2021-05-18 | |
| 2020-12-31 | $1,230,706 | 13,033 | Shares | Sole | 2021-02-12 | |
| 2020-09-30 | $969,082 | 11,144 | Shares | Sole | 2020-11-16 | |
| 2020-06-30 | $1,100,396 | 12,599 | Shares | Sole | 2020-08-14 | |
| 2020-03-31 | $827,550 | 10,037 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||